These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 7859583)

  • 21. The Physiology of the Gastric Parietal Cell.
    Engevik AC; Kaji I; Goldenring JR
    Physiol Rev; 2020 Apr; 100(2):573-602. PubMed ID: 31670611
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of IY-81149, a newly developed proton pump inhibitor, on gastric acid secretion in vitro and in vivo.
    Kwon D; Chae JB; Park CW; Kim YS; Lee SM; Kim EJ; Huh IH; Kim DY; Cho KD
    Arzneimittelforschung; 2001; 51(3):204-13. PubMed ID: 11304936
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Turnover of the gastric H+,K(+)-adenosine triphosphatase alpha subunit and its effect on inhibition of rat gastric acid secretion.
    Gedda K; Scott D; Besancon M; Lorentzon P; Sachs G
    Gastroenterology; 1995 Oct; 109(4):1134-41. PubMed ID: 7557078
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The long-lasting effect of TU-199, a novel H+, K(+)-ATPase inhibitor, on gastric acid secretion in dogs.
    Uchiyama K; Wakatsuki D; Kakinoki B; Takeuchi Y; Araki T; Morinaka Y
    J Pharm Pharmacol; 1999 Apr; 51(4):457-64. PubMed ID: 10385219
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of histamine2 receptor in increased expression of rat gastric H(+)-K(+)-ATPase alpha-subunit induced by omeprazole.
    Tari A; Yamamoto G; Sumii K; Sumii M; Takehara Y; Haruma K; Kajiyama G; Wu V; Sachs G; Walsh JH
    Am J Physiol; 1993 Oct; 265(4 Pt 1):G752-8. PubMed ID: 8238359
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of the inhibitory activity of tenatoprazole on the gastric H+,K+ -ATPase in vitro and in vivo.
    Shin JM; Homerin M; Domagala F; Ficheux H; Sachs G
    Biochem Pharmacol; 2006 Mar; 71(6):837-49. PubMed ID: 16405921
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In Esophageal Squamous Cells From Eosinophilic Esophagitis Patients, Th2 Cytokines Increase Eotaxin-3 Secretion Through Effects on Intracellular Calcium and a Non-Gastric Proton Pump.
    Odiase E; Zhang X; Chang Y; Nelson M; Balaji U; Gu J; Zhang Q; Pan Z; Spechler SJ; Souza RF
    Gastroenterology; 2021 May; 160(6):2072-2088.e6. PubMed ID: 33581123
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The continuing development of gastric acid pump inhibitors.
    Sachs G; Shin JM; Besancon M; Prinz C
    Aliment Pharmacol Ther; 1993; 7 Suppl 1():4-12, discussion 29-31. PubMed ID: 8387826
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modulations in extracellular calcium lead to H
    Kitay AM; Schneebacher MT; Schmitt A; Heschl K; Kopic S; Alfadda T; Alsaihati A; Link A; Geibel JP
    Am J Physiol Gastrointest Liver Physiol; 2018 Jul; 315(1):G36-G42. PubMed ID: 29517927
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The mechanism of action of omeprazole--a survey of its inhibitory actions in vitro.
    Wallmark B; Lorentzon P; Larsson H
    Scand J Gastroenterol Suppl; 1985; 108():37-51. PubMed ID: 2988109
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Progress with proton pump inhibition.
    Bell NJ; Hunt RH
    Yale J Biol Med; 1992; 65(6):649-57;discussion 689-92. PubMed ID: 1341069
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Omeprazole: mode of action and effect on acid secretion in animals.
    Wallmark B
    Scand J Gastroenterol Suppl; 1989; 166():12-8. PubMed ID: 2557668
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Physiology and pharmacology of the parietal cell.
    Helander HF
    Baillieres Clin Gastroenterol; 1988 Jul; 2(3):539-54. PubMed ID: 3048449
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of gastrin/CCK-B receptor in the regulation of gastric acid secretion in rat.
    Tari A; Kamiyasu T; Yonei Y; Hamada M; Sumii M; Sumii K; Kajiyama G; Dimaline R
    Dig Dis Sci; 1997 Sep; 42(9):1901-7. PubMed ID: 9331153
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Revealing the Mechanistic Pathway of Acid Activation of Proton Pump Inhibitors To Inhibit the Gastric Proton Pump: A DFT Study.
    Jana K; Bandyopadhyay T; Ganguly B
    J Phys Chem B; 2016 Dec; 120(51):13031-13038. PubMed ID: 27992223
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The second generation of gastric antisecretory agents: omeprazole].
    Souquet JC
    Rev Med Interne; 1988; 9(5):538-44. PubMed ID: 3067302
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Studies on the intracellular pharmacodynamic properties of proton pump inhibitors and the inhibitory mechanism of acid secretion].
    Saito E; Matsuo Y
    Nihon Rinsho; 1992 Jan; 50(1):18-25. PubMed ID: 1311783
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Properties of the reversible, K(+)-competitive inhibitor of the gastric (H+/K+)-ATPase, SK&F 97574. II. Pharmacological properties.
    Parsons ME; Rushant B; Rasmussen TC; Leach C; Ife RJ; Postius S; Pope AJ
    Biochem Pharmacol; 1995 Nov; 50(10):1551-6. PubMed ID: 7503756
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An amino acid transporter involved in gastric acid secretion.
    Kirchhoff P; Dave MH; Remy C; Kosiek O; Busque SM; Dufner M; Geibel JP; Verrey F; Wagner CA
    Pflugers Arch; 2006 Mar; 451(6):738-48. PubMed ID: 16308696
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Restoration of acid secretion following treatment with proton pump inhibitors.
    Shin JM; Sachs G
    Gastroenterology; 2002 Nov; 123(5):1588-97. PubMed ID: 12404233
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.